Donor Search and Matching (HLA Typing)

Donor Search and Matching (HLA Typing)

Donor Search and Matching is the critical first step for any allogeneic bone marrow or stem cell transplant. It involves identifying specific genetic markers called Human Leukocyte Antigens (HLA) to ensure the donor's immune system is compatible with the recipient's body. Through high-resolution DNA sequencing and global registry integration, this process minimizes the risk of transplant rejection and Graft-versus-Host Disease (GVHD), providing the foundation for a successful and durable recovery.

When You Should Consider HLA Typing

• Immediately upon diagnosis of high-risk Leukemia or Aplastic Anemia where a transplant is likely.

• When a sibling or close relative is available to test for a potential 10/10 genetic match.

• If a patient requires a life-saving transplant but does not have a matched family member.

• Before initiating a search in national or international bone marrow registries.

• For couples with inherited blood disorders (like Thalassemia) to screen for a compatible "Savior Sibling."

• To determine the feasibility of a Haploidentical (half-match) transplant from a parent or child.

Conditions That Require Specialized Matching

• Acute Myeloid Leukemia (AML) requiring a precise match to balance the Graft-versus-Tumor effect.

• Severe Combined Immunodeficiency (SCID) where an identical immune match is vital.

• High-risk Myelodysplastic Syndrome (MDS) where the age of the donor also becomes a critical factor.

• Patients from ethnic minority backgrounds who may require a wider search across global databases.

• Cases where a previous transplant was unsuccessful due to donor-specific antibodies.

How Donor Search and Matching Is Performed

• A blood or cheek swab sample is collected from the patient to establish their HLA profile.

• Next-Generation Sequencing (NGS) is used to analyze five primary HLA loci (A, B, C, DRB1, and DQB1).

• Sibling testing is conducted first, as there is a 25% biological probability of a perfect match.

• If no family match exists, a preliminary search is launched in global and national donor registries.

• Potential unrelated donors are identified and contacted for "confirmatory typing."

• AI-driven search algorithms predict which donors are most likely to be available and healthy for donation.

Innovations in HLA Matching

• Next-Generation Sequencing (NGS)High-resolution DNA typing that eliminates genetic "ambiguities" and provides 100% accuracy in a single test.

• AI-Powered Search AlgorithmsPredictive tools that analyze global registry data to find the best possible donor in a fraction of the traditional time.

• Donor-Specific Antibody (DSA) ScreeningAdvanced testing to see if the recipient's body has pre-existing "attacks" planned against a specific donor’s cells.

• Virtual Cross-MatchingA digital simulation of the transplant to predict compatibility before the physical cells are even requested.

• Non-Inherited Maternal Antigen (NIMA) TestingSpecialized screening for cord blood units that allows for better outcomes even in "mismatched" cases.

• Rapid-Turnaround Lab ProtocolsModern laboratory workflows that can provide high-resolution matching results in 14 days or less.

Pre-Procedure Preparation

• Early identification of all biological siblings to begin the "Related Donor" screening process.

• Counseling for family members to explain the non-invasive nature of HLA testing (swab or blood draw).

• Registration with national and international bone marrow donor databases (such as DATRI or NMDP).

• Financial planning for potential international donor procurement fees if no local match is found.

• Discussion with a transplant coordinator to understand the "Search Hierarchy" (Sibling > Unrelated > Haploidentical).

Pre-Procedure Tests

• High-Resolution HLA Typing (6-Loci or 11-Loci) for the most detailed genetic map.

• Confirmatory HLA Typing to verify the match before the donor's cells are collected.

• Blood Group (ABO) and Rh factor matching, although this is secondary to HLA compatibility.

• Viral marker screening (CMV, EBV, HIV, Hepatitis) for both the patient and the potential donor.

• Mixed Lymphocyte Reaction (MLR) tests in complex cases to observe cellular compatibility in a lab setting.

Why Specialized Matching Is Highly Effective

• Achieves the "Gold Standard" 10/10 match, which dramatically reduces the risk of Graft-versus-Host Disease.

• AI-assisted searches significantly shorten the "time to transplant," which is vital for aggressive diseases.

• High-resolution NGS ensures that hidden genetic differences are identified before the transplant begins.

• Opens the door to Haploidentical (half-match) transplants, ensuring nearly every patient has a donor.

• Minimizes the risk of primary graft failure by selecting donors with the highest "engraftment potential."

The Search and Coordination Phase

• The transplant coordinator manages communication with donor registries and courier services.

• Regular updates are provided to the patient as donors move from "preliminary match" to "confirmed."

• If a donor is found abroad, the team coordinates the cold-chain transport of the cells.

• The matching process concludes when a donor is medically cleared and a collection date is set.

• For cord blood searches, units are reserved and tested for cell count and viability.

Life After Successful Matching

• Increased confidence and peace of mind as the patient enters the conditioning phase.

• Higher probability of long-term survival and a cure due to the selection of the optimal genetic match.

• Reduction in the need for long-term, high-dose immunosuppressant medications after transplant.

• Successful "rebuilding" of the immune system using a compatible genetic blueprint.

• Potential to save a life through the altruistic participation of a matched stranger or family member.